Chlorambucil Articles

Improved overall survival in most common leukemia treated with Roche’s MabThera

8 December 2009

Genmab plans to initiate four ofatumumab studies

1 September 2008

FDA clears Cephalon's Treanda for CLL

31 March 2008

Bayer's MabCampath cleared for CLL by EC

14 January 2008

CHMP advocates MabCampath approval

29 October 2007

FDA approves Campath as single agent for B-CLL

1 October 2007

Cephalon plans to file Treanda NDA in 3rd qtr

9 July 2007

Fludara cleared for first-line use in CLL

17 February 2003

M&I's MabCampath is approved by EMEA

12 July 2001

MabCampath nears EU approval for CLL

30 March 2001

Clinical Trial News In Brief

28 May 1998

LeukoSite Lead Product May Be On Market By 2000

28 May 1998

Sandoz MDR Drug Shows Promise In Early Trials

13 November 1995

COMPANIES HAVE SAY IN UK NHS DRUG ENQUIRY

14 February 1994

NOVEL TREATMENT FOR BREAST CANCER

2 November 1992

Showing 1-15 of 15 articles

Go to beginningPrevious
  • 1
NextGo to end